ECTMBICS 2027 brings together a broad international scientific and professional community across translational medicine, biotechnology, clinical research, pharmaceutical development, precision medicine, digital health, regulatory science, healthcare systems, and clinical implementation. The conference is designed to connect fundamental and applied research with clinical practice, patient outcomes, technology development, and responsible healthcare innovation.
Final themes, session titles, presentation categories, and programme structure may be refined as accepted abstracts and invited contributions are scheduled.
The ECTMBICS 2027 programme is designed to balance scientific depth, clinical relevance, translational value, healthcare implementation, regulatory awareness, interdisciplinary learning, and industry engagement.
Sessions may include keynote and invited presentations, oral research sessions, poster presentations, young-researcher contributions, clinical and translational panels, case-based discussions, regulatory and industry sessions, and focused exchanges on therapeutics development, precision medicine, biotechnology, digital health, and patient-centred innovation.
These tracks reflect the main scientific and professional scope of ECTMBICS 2027. Related interdisciplinary submissions are also welcome and may be allocated to the most appropriate session.
The following clusters illustrate additional topic areas that may appear across keynote sessions, oral presentations, poster sessions, interdisciplinary panels, industry discussions, and special scientific sessions.
Clinical translation, implementation science, evidence pathways, care integration, patient-centred innovation, and real-world adoption.
Therapeutics, diagnostics, platform technologies, product development, IP strategy, licensing, and commercialisation pathways.
Trial design, adaptive and decentralised studies, patient recruitment, real-world evidence, data quality, and clinical operations.
Regulatory pathways, safety, ethics, market access, reimbursement, payer evidence, portfolio strategy, and strategic partnerships.
AI in healthcare, digital therapeutics, biomarkers, diagnostics, omics, data governance, interoperability, and personalised medicine.
Venture building, funding strategy, hospital adoption, health-system procurement, international partnerships, and innovation scale-up.
The congress is designed to connect scientific discovery with clinical practice and healthcare implementation. The programme therefore addresses research quality alongside translation, clinical validation, regulatory science, market access, health-system adoption, interdisciplinary collaboration, and measurable patient impact.
This broad conference framework creates space for researchers, clinicians, biotechnology and pharmaceutical professionals, health-system specialists, regulators, innovators, students, and institutional partners to exchange evidence and develop practical pathways from discovery to implementation.
These topics are relevant to clinicians, translational medicine specialists, biomedical researchers, biotechnology professionals, pharmaceutical scientists, clinical-trial teams, digital-health specialists, regulatory experts, healthcare professionals, academic researchers, doctoral candidates, early-career researchers, and industry or institutional partners.
Contributions may be considered as keynote or invited presentations, oral presentations, poster presentations, young-researcher sessions, panel contributions, institutional or industry sessions, and other programme formats appropriate to the accepted work.
Abstracts may be considered for oral or poster presentation according to scientific relevance, quality, programme capacity, and the review process. Invited and keynote sessions complement the submitted programme, while non-presenting delegates may attend without submitting an abstract.
Expert perspectives and major developments.
Selected research presented in scientific sessions.
Interactive discussion of accepted research.
Attend and network without presenting.
Researchers, clinicians, students, biotechnology and pharmaceutical professionals, healthcare specialists, and interdisciplinary teams are invited to submit abstracts for oral or poster presentation. Related topics beyond the listed tracks may also be considered where they fit the congress scope.